cinidon-ethyl and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

cinidon-ethyl has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for cinidon-ethyl and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro. Journal of food science, 2019, Volume: 84, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lotus	2019

Article

Year

Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro.

Journal of food science, 2019, Volume: 84, Issue:4

Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lotus

2019